Director, Chief Executive Officer · Cue Biopharma, Inc. · Common Stock
Side
M
Value
—
Shares
109.2K
Price
—
Executed
Aug 12, 2026
Disclosed
Aug 14, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Aug 12 executedAug 14, 2026 disclosed
CUE · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+5 / 25
No reported dollar value · 16.7% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Lin Shao-Lee filed this Form 4 reporting a option exercise of CUE on Aug 12, 2026. It became public on Aug 14, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, Chief Executive Officer
Lin Shao-Leecik:0001725092
Issuer
Cue Biopharma, Inc.cik:0001645460
Revision history · 0
No field has changed since this record was first ingested.
